OpGen gains as China grants key patent

CapForce

26/01/2023 13:32

** OpGen Inc's shares  OPGN.O  up 11.2% at $2.28 premarket
    ** Diagnostics firm says its subsidiary unit, Ares Genetics,
has been granted key patent in China  urn:newsml:reuters.com:*:nGNX9PfRRY
    ** The patent covers method for identification of genetic
variations, which would aid in differentiation of bacteria 
susceptible to antibiotic therapy and strains that are
antibiotic resistant
    ** Antibiotic-resistant infection is on the rise and
currently account for about 1.57 million deaths a year - OPGN
    ** OPGN fell ~86% last year
 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))